Skip to main content
Equibles

Michael Higgins

Board Member

Korsana Biosciences, Inc. (KRSA)

Equibles does not estimate personal net worth.

Get an email with a short summary when Korsana Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.

Get KRSA alerts

About Michael Higgins

Michael Higgins is recorded as Board Member at Korsana Biosciences, Inc. (KRSA) since November 30, 2023. Korsana Biosciences, Inc. reported in an 8-K filed September 11, 2026 that Michael Higgins resigned as board of directors, effective September 8, 2026. Korsana Biosciences, Inc. reported in an 8-K filed December 1, 2023 that Michael Higgins was appointed Board of Directors, effective November 30, 2023. Korsana Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Korsana Biosciences, Inc. includes Jonathan Violin, Ph.D. (CEO and Board Member), Regina M. Graul (CEO and Board Member), Tomas Kiselak (Chairman and Board Member) and 7 others.

“On September 8, 2026, Errol B. De Souza, Ph.D., Regina M. Graul, Ph.D., Peter M. Hecht, Ph.D., Michael Higgins, Steven E. Hyman, M.D. and Dina Katabi, Ph.D. resigned from the Company’s board of directors and its committees on which they respectively served, which resignations were not the result of any disagreements with the Company relating to the Company’s operations, policies or practices.”
Korsana Biosciences, Inc. Form 8-K, filed September 11, 2026 · Read the filing
“On November 30, 2023, the Board of Directors of Cyclerion Therapeutics, Inc. (the "Company") voted to increase the size of the Board of Directors to six (6) directors and also voted to elect each of Michael Higgins and Dina Katabi, Ph.D. to the Board of Directors, effective immediately.”
Korsana Biosciences, Inc. Form 8-K, filed December 1, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Korsana Biosciences, Inc.

Recent activity